A
Anca Pantea Stoian
Researcher at Carol Davila University of Medicine and Pharmacy
Publications - 171
Citations - 1805
Anca Pantea Stoian is an academic researcher from Carol Davila University of Medicine and Pharmacy. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 122 publications receiving 759 citations. Previous affiliations of Anca Pantea Stoian include University of Bucharest & Yahoo!.
Papers
More filters
Journal ArticleDOI
COVID-19 and diabetes management: What should be considered?
TL;DR: In this paper, the authors proposed a method to improve the quality of the data collected by the data collection system.2019 Elsevier B.V. All rights reserved, b.v.
Journal ArticleDOI
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.
Journal ArticleDOI
Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department
Elena-Codruța Dobrică,Mihnea-Alexandru Găman,Matei-Alexandru Cozma,Ovidiu Gabriel Bratu,Anca Pantea Stoian,Camelia Cristina Diaconu +5 more
TL;DR: In this study, type 2 diabetes mellitus patients received more drugs than their non-diabetes counterparts and were exposed to more drug-drug and food-drug interactions.
Journal ArticleDOI
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.
Anca Pantea Stoian,Mihaela Pricop-Jeckstadt,Adrian Pana,Bogdan Vasile Ileanu,Ruxandra Schitea,Marius Geanta,Doina Catrinoiu,Andra Iulia Suceveanu,Cristian Serafinceanu,Silviu Pituru,Catalina Poiana,Bogdan Timar,Cornelia Nitipir,Simona Parvu,Andreea Letiția Arsene,Laura Mazilu,Antonela Toma,Razvan Hainarosie,Antonio Ceriello,Manfredi Rizzo,Manfredi Rizzo,Viorel Jinga +21 more
TL;DR: Evidence shows that age-dependent pairs of comorbidities could be a negative prognosis factor for the severity of disease for the SARS-CoV 2 infection.
Journal ArticleDOI
Low-density lipoprotein cholesterol lowering treatment: the current approach.
Irina Crismaru,Anca Pantea Stoian,Ovidiu Gabriel Bratu,Mihnea-Alexandru Găman,Ana Maria Alexandra Stănescu,Nicolae Bacalbasa,Camelia Cristina Diaconu +6 more
TL;DR: The present narrative review discusses the latest guidelines of the European Atherosclerosis Society/European Society of Cardiology for the management of dyslipidemia, focusing on LDLc-lowering drugs that are either already available on the market or under development.